Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Cheeseman

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
The Journal of the American Academy of Orthopaedic Surgeons|October 16, 2018
Response to Letter to the Editor: Costs and Radiographic Outcomes of Rotational Ankle Fractures Treated by Orthopaedic Surgeons With or Without Trauma Fellowship TrainingWalter W Virkus, Robert J Wetzel, Todd O McKinley, et al.
Journal of Virology|March 1, 1994
Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapyD D Richman, D Havlir, J Corbeil, et al.
Journal of Medicinal Chemistry|March 6, 1992
Perfluorocarbon-based antidiabetic agentsK L Kees, T M Smith, M L McCaleb, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Establishing standards: harmonising coding principles for a minimal cancer dataset in the OMOP Common Data ModelA Ajmal, O Bouissou, J Brash, et al.
British Journal of Cancer|January 18, 2017
A randomised phase II trial and feasibility study of palliative chemotherapy in frail or elderly patients with advanced gastroesophageal cancer (321GO)P S Hall, S R Lord, M Collinson, et al.
Journal of Medicinal Chemistry|March 12, 1999
Corticotropin-releasing hormone receptor antagonists: framework design and synthesis guided by ligand conformational studiesC N Hodge, P E Aldrich, Z R Wasserman, et al.
ESMO Real World Data and Digital Oncology|April 20, 2026
Optimisation and validation of line-of-therapy advancement algorithms in advanced/metastatic non-small-cell lung cancer: an I-O Optimise studyS Lay-Flurrie, A Greystoke, C Rault, et al.
ESMO Open|September 4, 2024
Efficacy of chemotherapy after progression during or following PARPi exposure in ovarian cancerA Xu-Vuillard, C Guerin-Charbonnel, F Bocquet, et al.
Journal of Medicinal Chemistry|March 12, 1999
Non-peptide corticotropin-releasing hormone antagonists: syntheses and structure-activity relationships of 2-anilinopyrimidines and -triazinesA G Arvanitis, P J Gilligan, R J Chorvat, et al.
Journal of Medicinal Chemistry|March 12, 1999
Synthesis, corticotropin-releasing factor receptor binding affinity, and pharmacokinetic properties of triazolo-, imidazo-, and pyrrolopyrimidines and -pyridinesR J Chorvat, R Bakthavatchalam, J P Beck, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
The Journal of the American Academy of Orthopaedic Surgeons|October 16, 2018
Response to Letter to the Editor: Costs and Radiographic Outcomes of Rotational Ankle Fractures Treated by Orthopaedic Surgeons With or Without Trauma Fellowship TrainingWalter W Virkus, Robert J Wetzel, Todd O McKinley, et al.
Journal of Virology|March 1, 1994
Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapyD D Richman, D Havlir, J Corbeil, et al.
Journal of Medicinal Chemistry|March 6, 1992
Perfluorocarbon-based antidiabetic agentsK L Kees, T M Smith, M L McCaleb, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Establishing standards: harmonising coding principles for a minimal cancer dataset in the OMOP Common Data ModelA Ajmal, O Bouissou, J Brash, et al.
British Journal of Cancer|January 18, 2017
A randomised phase II trial and feasibility study of palliative chemotherapy in frail or elderly patients with advanced gastroesophageal cancer (321GO)P S Hall, S R Lord, M Collinson, et al.
Journal of Medicinal Chemistry|March 12, 1999
Corticotropin-releasing hormone receptor antagonists: framework design and synthesis guided by ligand conformational studiesC N Hodge, P E Aldrich, Z R Wasserman, et al.
ESMO Real World Data and Digital Oncology|April 20, 2026
Optimisation and validation of line-of-therapy advancement algorithms in advanced/metastatic non-small-cell lung cancer: an I-O Optimise studyS Lay-Flurrie, A Greystoke, C Rault, et al.
ESMO Open|September 4, 2024
Efficacy of chemotherapy after progression during or following PARPi exposure in ovarian cancerA Xu-Vuillard, C Guerin-Charbonnel, F Bocquet, et al.
Journal of Medicinal Chemistry|March 12, 1999
Non-peptide corticotropin-releasing hormone antagonists: syntheses and structure-activity relationships of 2-anilinopyrimidines and -triazinesA G Arvanitis, P J Gilligan, R J Chorvat, et al.
Journal of Medicinal Chemistry|March 12, 1999
Synthesis, corticotropin-releasing factor receptor binding affinity, and pharmacokinetic properties of triazolo-, imidazo-, and pyrrolopyrimidines and -pyridinesR J Chorvat, R Bakthavatchalam, J P Beck, et al.
Pageof 3